Who is sponsoring NCT03077594?

NCT03077594 is sponsored by Mayo Clinic.

What drugs are being tested in NCT03077594?

Interventions in NCT03077594: Mucosal Impedance, Research Biopsies, Volumetric Laser Endomicroscopy.

What condition does NCT03077594 study?

NCT03077594 studies Barrett's Esophagus With Dysplasia.

Is NCT03077594 still recruiting?

NCT03077594 is currently completed. Last updated 18 January 2023.

Last reviewed 2023-01-18 · How we verify

NCT03077594

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of the Neo-squamous Epithelial Barrier

Completed Last updated 18 January 2023

What this trial tests

trial testing Mucosal Impedance in Barrett's Esophagus With Dysplasia in 53 participants. Completed in 29 June 2022.

Timeline

26 September 2016

Primary endpoint
1 November 2019

29 June 2022

Quick facts

Lead sponsor	Mayo Clinic
Status	Completed
Study type	OBSERVATIONAL
Enrollment	53
Start date	26 September 2016
Primary completion	1 November 2019
Estimated completion	29 June 2022
Sites	2 locations across United States

Drugs / interventions tested

Mucosal Impedance
Research Biopsies
Volumetric Laser Endomicroscopy

Conditions studied

Barrett's Esophagus With Dysplasia — all drugs for Barrett's Esophagus With Dysplasia →

Sponsor

Mayo Clinic

Who can join

Adults 18 to 90, any sex, with Barrett's Esophagus With Dysplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To prospectively assess the functional aspects of the the esophageal squamous epithelial barrier and correlate this with tissue inflammation and intercellular space dilation in patients who have successfully completed endoscopic radiofrequency ablation versus balloon cryotherapy for Barrett's Esophagus related metaplasia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03077594 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 18 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03077594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing